Market Cap

Nabriva Therapeutics plc Market Capitalization:

$4.5 Million

USD as of Oct. 1, 2023

business Nabriva Therapeutics plc Company Profile

Nabriva Therapeutics plc Main Stock Listing

NASDAQ: NBRV

Market Capitalization History of Nabriva Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Nabriva Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2023 $4.7 M 220.91%
Jan. 1, 2022 $1.5 M -81.56%
Jan. 1, 2021 $8.0 M -80.59%
Jan. 1, 2020 $41.4 M -28.95%
Jan. 1, 2019 $58.2 M -70.63%
Jan. 1, 2018 $198.2 M -18.82%
Jan. 1, 2017 $244.2 M -5.90%
Jan. 1, 2016 $259.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Nabriva Therapeutics plc Categories

Ireland languages Healthcare languages Biotechnology
Ireland Healthcare Ireland Biotechnology

Stocks & Indices

Nabriva Therapeutics plc has the following listings and related stock indices.


Stock: NASDAQ: NBRV

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.